AbSorber AB announced today a new global distribution partner for the transplantation diagnostic product XM-ONE® effective from July 1, 2009. The new distributor, Olerup International, gives AbSorber the opportunity to sell XM-ONE® and future products globally with a highly specialized sales force within the Transplantation segment. Olerup International has distribution channels in Europe, USA and other highly prioritized countries for the transplantation segment. At the same time AbSorber has agreed with Becton Dickinson to terminate the current distribution agreement.
- Our new partner gives us an excellent distribution network in all prioritized markets. We will have a sales force committed to the HLA labs and the transplantation units in Europe and USA, says Anders Karlsson, CEO at AbSorber. Olerup International will put significant resources behind XM-ONE® and have started to recruit additional sales representatives, both in Europe and USA.
AbSorber has since Q4 2008 launched XM-ONE® in US to the top 30 transplantation centers. The launch has been very successful and XM-ONE® has in a short time frame build a foundation for continuing growth in US. The sales model for highly specialized products used in US will now be transferred to the European market and other selected countries globally.
For more information contact Anders Karlsson, CEO AbSorber, tel. + 46 70 918 00 10
About XM-ONE®
XM-ONE® is the first standardized test that can detect antibodies against the cells that line the inside of blood vessels. These endothelial cells are the first point of contact between the transplanted organ and the recipient's immune system. Anti-endothelial cell antibodies have been shown to play a key role in causing post-transplantation rejections. The study has awakened great scientific interest and several other transplantation centers have included XM-ONE® their clinical assessment of patients before transplantation.
For more information contact: Anders Karlsson, CEO AbSorber, tel. + 46 70 918 00 10
Also visit www.absorber.se
AbSorber develops products that facilitate more successful transplantations. AbSorber's first product, the transplantation test XM-ONE® detects key antibodies responsible for posttransplantation rejection reactions. XM-ONE® is already CE marked and FDA approved for sales in the EU and U.S.